CYSLTR1
Cysteinyl leukotriene receptor 1
Also known as: CLTR1_HUMAN, CysLT(1), CysLT1, CYSLT1R
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y271
- Gene
- CYSLTR1
- Ensembl
- ENSG00000173198
- Chromosome
- X
- Canonical length
- 337 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes a member of the G-protein coupled receptor 1 family. The encoded protein is a receptor for cysteinyl leukotrienes, and is involved in mediating bronchoconstriction via activation of a phosphatidylinositol-calcium second messenger system. Activation of the encoded receptor results in contraction and proliferation of bronchial smooth muscle cells, eosinophil migration, and damage to the mucus layer in the lung. Upregulation of this gene is associated with asthma and dysregulation may also be implicated in cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2013]
Canonical amino-acid sequenceUniProt
337 residues, UniProt reviewed canonical sequence.
>Q9Y271|CYSLTR1
1 MDETGNLTVS SATCHDTIDD FRNQVYSTLY SMISVVGFFG NGFVLYVLIK TYHKKSAFQV
61 YMINLAVADL LCVCTLPLRV VYYVHKGIWL FGDFLCRLST YALYVNLYCS IFFMTAMSFF
121 RCIAIVFPVQ NINLVTQKKA RFVCVGIWIF VILTSSPFLM AKPQKDEKNN TKCFEPPQDN
181 QTKNHVLVLH YVSLFVGFII PFVIIIVCYT MIILTLLKKS MKKNLSSHKK AIGMIMVVTA
241 AFLVSFMPYH IQRTIHLHFL HNETKPCDSV LRMQKSVVIT LSLAASNCCF DPLLYFFSGG
301 NFRKRLSTFR KHSLSSVTYV PRKKASLPEK GEEICKVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CYSLTR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 11 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 11 nTPM
- spleen: 10 nTPM
- lymph node: 8.9 nTPM
- appendix: 7.1 nTPM
- esophagus: 6.9 nTPM
- lung: 6.9 nTPM
Single-cell type
- innate lymphoid cells: 130 nCPM
- pdcs: 129 nCPM
- b-cells: 90 nCPM
- plasma cells: 90 nCPM
- microglia: 82 nCPM
- hofbauer cells: 68 nCPM
Immune cell
- eosinophil: 86 nTPM
- neutrophil: 45 nTPM
- non-classical monocyte: 31 nTPM
- intermediate monocyte: 27 nTPM
- basophil: 19 nTPM
- memory B-cell: 19 nTPM
Brain region
- spinal cord: 1.8 nTPM
- medulla oblongata: 1.7 nTPM
- pons: 1.6 nTPM
- white matter: 1.6 nTPM
- choroid plexus: 1.3 nTPM
- hypothalamus: 1.2 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0.01
- gnomAD missense Z
- -0.77
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- calcium ion transport
- cell surface receptor signaling pathway
- chemotaxis
- defense response
- endothelium development
- establishment of localization in cell
- inflammatory response to antigenic stimulus
- neuropeptide signaling pathway
- positive regulation of cytosolic calcium ion concentration
- reactive oxygen species biosynthetic process
- respiratory gaseous exchange by respiratory system
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CYSLTR1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CYSLTR1 as an antibody target. Whether an autoantibody or antibody against CYSLTR1 could matter depends on whether native CYSLTR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CYSLTR1 is annotated at the cell surface, where native CYSLTR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CYSLTR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...